Re-Direct Cambridge Laboratories - Press area

Press area

Our latest press releases are available below.
(Please note: Adobe Acrobat Reader is required to view these files)

Download PDF22 June 2009
Biovail Announces Closing of Acquisition of Worldwide Rights to Tetrabenazine

Download PDF18 May 2009
Biovail Announces Acquisition of Worldwide Rights to Tetrabenazine

Press Archive

We are aiming to build one of Europe's foremost specialist pharmaceutical companies using private funds. That's one of the things that make Cambridge so interesting and exciting to work for.

David Wildy, Chief Financial Officer